Anlon Healthcare Limited (NSE:AHCL)
India · Delayed Price · Currency is INR 122.44
-0.49 (-0.40%)
At close: Feb 12, 2026
Anlon Healthcare Revenue
Anlon Healthcare had revenue of 355.78M INR in the quarter ending December 31, 2025, with 47.22% growth. This brings the company's revenue in the last twelve months to 1.70B. In the fiscal year ending March 31, 2025, Anlon Healthcare had annual revenue of 1.20B with 80.64% growth.
Revenue (ttm)
1.70B
Revenue Growth
+80.64%
P/S Ratio
3.80
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.20B | 537.17M | 80.64% |
| Mar 31, 2024 | 666.16M | -464.64M | -41.09% |
| Mar 31, 2023 | 1.13B | 556.91M | 97.04% |
| Mar 31, 2022 | 573.89M | 414.09M | 259.14% |
| Mar 31, 2021 | 159.80M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IOL Chemicals and Pharmaceuticals | 22.27B |
| Bajaj HealthCare | 6.12B |
| Aarey Drugs & Pharmaceuticals | 4.28B |
| NGL Fine-Chem | 4.08B |
| Infinium Pharmachem | 1.57B |
| Kimia Biosciences | 1.26B |
| Influx Healthtech | 1.24B |
| Smruthi Organics | 1.20B |